Shoulder Innovations, Inc. $SI Holdings Boosted by Roubaix Capital LLC

Roubaix Capital LLC raised its position in shares of Shoulder Innovations, Inc. (NYSE:SI) by 61.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 257,121 shares of the company’s stock after purchasing an additional 98,305 shares during the quarter. Roubaix Capital LLC’s holdings in Shoulder Innovations were worth $3,736,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of SI. Wells Fargo & Company MN boosted its position in shares of Shoulder Innovations by 66.3% in the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock worth $75,000 after buying an additional 2,094 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Shoulder Innovations during the third quarter valued at $28,000. Rhumbline Advisers acquired a new position in Shoulder Innovations during the third quarter valued at $54,000. Renaissance Technologies LLC purchased a new stake in Shoulder Innovations in the 4th quarter worth about $176,000. Finally, Blue Trust Inc. acquired a new stake in Shoulder Innovations during the 1st quarter worth about $228,000.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on SI shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Shoulder Innovations in a research note on Monday, June 29th. Piper Sandler reissued an “overweight” rating and issued a $19.00 price target (up from $18.00) on shares of Shoulder Innovations in a research report on Friday, May 8th. Five equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Shoulder Innovations has an average rating of “Moderate Buy” and a consensus price target of $21.00.

Insider Buying and Selling

In other Shoulder Innovations news, COO Matthew Fraser Ahearn sold 15,856 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $18.68, for a total value of $296,190.08. Following the transaction, the chief operating officer owned 273,320 shares in the company, valued at $5,105,617.60. The trade was a 5.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 29.00% of the stock is owned by company insiders.

Shoulder Innovations Trading Down 4.1%

Shares of NYSE:SI opened at $21.60 on Friday. The firm has a fifty day moving average of $17.76 and a two-hundred day moving average of $15.29. The company has a quick ratio of 10.04, a current ratio of 11.81 and a debt-to-equity ratio of 0.11. Shoulder Innovations, Inc. has a 12-month low of $10.92 and a 12-month high of $23.00. The firm has a market capitalization of $448.00 million and a P/E ratio of -0.13.

Shoulder Innovations (NYSE:SI) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The business had revenue of $16.71 million for the quarter. On average, equities analysts expect that Shoulder Innovations, Inc. will post -1.67 EPS for the current fiscal year.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.